Overview of current multiparametric magnetic resonance imaging approach in the diagnosis and staging of prostate cancer

  title={Overview of current multiparametric magnetic resonance imaging approach in the diagnosis and staging of prostate cancer},
  author={Hasan Riza Aydin and Volkan Kızılg{\"o}z and Berna Okudan Tekin},
  journal={The Kaohsiung Journal of Medical Sciences},

Role of apparent diffusion coefficient values in prostate diseases characterization on diffusion-weighted magnetic resonance imaging.

ADC values allow differentiation between normal and pathological prostate tissue and between indolent and clinically significant PCa but do not allow a definite differentiation between PCa, HG-PIN, and ASAP.

Decomposition of DCE-MRI Data for the Classification of Benign and Malignant Prostates

Nonnegative matrix factorization (NMF) can be used to analyze the components in DCE-MRI data of the prostate and shows that the characteristic curve with the earliest peak rises rapidly and declines rapidly can beused to classify the malignant and benign prostates accurately.

Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram

The established nomogram combining a biparametric MRI-based radiomics signature and PI-RADS could be utilized for noninvasive and accurate prediction of CS-PCa.

Effect of domain knowledge encoding in CNN model architecture—a prostate cancer study using mpMRI images

The results fail to demonstrate that PI-RADS-based modelling of CNN architecture can significantly improve performance of prostate cancer recognition using mpMRI.

Radiomics prediction model for the improved diagnosis of clinically significant prostate cancer on biparametric MRI.

Compared with the evaluation of clinical risk factors associated with PCa only, the radiomics-based machine learning model can improve the predictive accuracy for clinically significant PCa, in terms of both diagnostic performance and clinical net benefit.



Local staging of prostate cancer with MRI.

The current applications of conventional and advanced MRI techniques in the local staging of prostate cancer are reviewed.

Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management.

DCE-MRI is emerging as a useful clinical technique as part of a multi-parametric approach for evaluating the extent of primary and recurrent prostate cancer.

Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2‐weighted, dynamic contrast‐enhanced and diffusion‐weighted imaging

Study Type – Diagnostic (exploratory cohort) 
Level of Evidence 2b

Multimodality magnetic resonance imaging of prostate cancer.

Both routine T2-weighted and new MRI techniques in the imaging of prostate cancer (PCa) for focal therapy are reviewed, finding potential advantages of 3 Tesla MRI are adequate imaging without an endorectal coil.

MR imaging and MR spectroscopy in prostate cancer management.

Imaging localized prostate cancer: current approaches and new developments.

Although prostate cancer is the second leading cause of cancer death in men, imaging of localized prostate cancer remains limited and recent developments in imaging technologies, particularly MRI and PET, may lead to significant improvements in lesion detection and staging.

Multi-parametric MR imaging of transition zone prostate cancer: Imaging features, detection and staging.

The MR imaging features of TZ prostate cancers, the role of MR imaging in TZ cancer detection and staging, and recent advanced MR techniques will be discussed in light of the literature.

Advances in MR spectroscopy of the prostate.

Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy.

  • F. ClausH. HricakR. Hattery
  • Medicine, Physics
    Radiographics : a review publication of the Radiological Society of North America, Inc
  • 2004
Magnetic resonance (MR) imaging and hydrogen 1 MR spectroscopy of the prostate gland are performed during the same examination with a conventional clinical MR unit. Prostate zonal anatomy and

MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer.

  • H. Hricak
  • Medicine
    The British journal of radiology
  • 2005
The addition of 1H MRSI to MRI can improve prostate cancer detection and assessment of tumour volume; it also contributes indirectly to improved local staging and may offer a non-invasive means to better predict prostate cancer aggressiveness.